Abstract:Abstract Background Lung cancer remains the leading cause of mortality from malignant tumors, non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases, and individualized diagnosis and treatment is an effective trend. The individual characteristics of different traditional Chinese medicine (TCM) syndromes of NSCLC patients may be revealed by highly specific molecular profiles. Methods In this study, 10 NSCLC patients with Qi deficiency and Yin deficiency (QDYD) syndrome and 10 patients with Qi deficiency of lung-spleen (QDLS) syndrome in TNM stage III-IV as well as 10 healthy volunteers were enrolled. Aiming at the varied syndromes of NSCLC patients with “Yin deficiency” as the main difference, a proteomics research based on data-independent acquisition (DIA) was developed. Of the dysregulated proteins in NSCLC patients, lipid metabolism was significantly enriched. Thereafter, nontargeted lipidomics research based on UPLC-Q-TOF/MS was performed in 16 patients, with 8 individuals randomly selected from each syndrome group. Furthermore, the considerably different characteristics between the syndromes and pathological mechanisms of NSCLC were screened by statistical and biological integrations of proteomics and lipidomics and the differential metabolic pathways of the two similar syndromes were further explored. Besides, lipids biomarkers were verified by a clinically used anticancer Chinese medicine, and the level of key differential proteins in the two syndromes was also validated using ELISA. Results The results showed that glycerophospholipid metabolism, sphingolipid metabolism, glycolipid metabolism, and primary bile acid biosynthesis were altered in NSCLC patients and that glycerophospholipid metabolism was significantly changed between the two syndromes in lipidomics analysis. Among the proteins and lipids, ALDOC and lysophosphatidylcholine (LPCs) were revealed to have a strong relationship by statistical and biological integration analysis, and could effectively distinguish QDLS and QDYD syndromes. Notably, the patients with different syndromes had the most typical metabolic patterns in glycerophospholipid metabolism and glycolysis, reflecting the differences in the syndromes dominated by “Yin deficiency”. Conclusions ALDOC and LPCs could be employed for the differentiation of NSCLC patients with QDLS and QDYD syndromes, and “Yin deficiency” might be associated with glycerophospholipid metabolism and glycolysis pathway. The results provided a theoretical basis for “Syndrome differentiation” in TCM diagnosis. Moreover, the developed integrated strategy could also provide a reference for individualized diagnosis and treatment of other diseases.

The syndromes of lung cancer and compatibility of medicine in Traditional Chinese Medicine science treatment based on Clustering Algorithm

Analysis of the Cluster Efficacy and Prescription Characteristics of Traditional Chinese Medicine Intervention for Non-Small Cell Lung Cancer Based on a Clustering Algorithm.

A method for finding groups of related herbs in traditional chinese medicine

Out-of-set Association Analysis of Lung Cancer Drugs and Symptoms Based on Clinical Case Data Mining.

Cluster analysis for syndromes of real-world coronary heart disease with angina pectoris

Classification And Diagnosis Of Syndromes In Chinese Medicine In The Context Of Coronary Heart Disease Model Based On Data Mining Methods

Modern Bioinformatics Meets Traditional Chinese Medicine.

A real-world data analysis-based study of Chinese medicine treatment patterns after breast cancer surgery

Correspondence Analysis Between Traditional Chinese Medicine (TCM) Syndrome Differentiation and Histopathology in Colorectal Cancer

Latent tree models and diagnosis in traditional Chinese medicine

Integrated DIA proteomics and lipidomics analysis on non-small cell lung cancer patients with TCM syndromes

The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases

Research On Syndrome Classification And Risk Factors Extraction Of Tibetan Medicine Based On Clustering

Univariate Analysis of Syndrome Differentiation in Traditional Chinese Medicine and Clinical Correlative Factors in Gastric Cancer

Study on Medication Regularity of Compound Herbal Formulae for Treating Advanced ;Non-small Lung Cancer Based on Data Mining

A data-driven method for syndrome type identification and classification in traditional Chinese medicine

Treating Different Diseases With the Same Method—A Traditional Chinese Medicine Concept Analyzed for Its Biological Basis

End-to-End Models to Imitate Traditional Chinese Medicine Syndrome Differentiation in Lung Cancer Diagnosis: Model Development and Validation

Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: A case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer

[Diagnosis and Treatment Rule of Traditional Chinese Medicine for Syndrome Factors of Chronic Congestive Heart Failure: a Study Based on Shannon Entropy Method].

Applying Complex System Entropy Cluster Algorithm to Mining Principle of Herbal Combinations in Traditional Chinese Medicine